Startup offering Alzheimer's diagnostic test gets cash infusion

05/22/2013 | VentureBeat

Neurotrack, a startup that offers a diagnostic test for Alzheimer's disease, has received a $90,000 infusion from angel investors. The test detects impairments in the hippocampus of the brain and can identify patients who are likely to develop the disease years ahead of time. Patients who learn about their Alzheimer's risk early can take steps to delay the disease by exercising, taking medication and changing their diets.

View Full Article in:

VentureBeat

Published in Briefs: